BlackRock Institutional Trust’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$19.8M Buy
1,434,807
+159,346
+12% +$2.56M ﹤0.01% 1971
2016
Q3
$23M Buy
1,275,461
+181,063
+17% +$2.91M ﹤0.01% 1789
2016
Q2
$15.7M Sell
1,094,398
-12,810
-1% -$174K ﹤0.01% 2002
2016
Q1
$13.2M Buy
1,107,208
+6,770
+0.6% +$71K ﹤0.01% 2090
2015
Q4
$14.6M Buy
1,100,438
+17,225
+2% +$212K ﹤0.01% 2073
2015
Q3
$11.6M Sell
1,083,213
-107,418
-9% -$1.17M ﹤0.01% 2189
2015
Q2
$9.59M Buy
1,190,631
+29,178
+3% +$214K ﹤0.01% 2434
2015
Q1
$7.68M Buy
1,161,453
+67,140
+6% +$458K ﹤0.01% 2554
2014
Q4
$6.97M Buy
1,094,313
+43,666
+4% +$352K ﹤0.01% 2563
2014
Q3
$10.4M Buy
1,050,647
+709
+0.1% +$7.57K ﹤0.01% 2315
2014
Q2
$11.8M Buy
1,049,938
+1,825
+0.2% +$19.6K ﹤0.01% 2324
2014
Q1
$12.7M Buy
1,048,113
+21,320
+2% +$272K ﹤0.01% 2263
2013
Q4
$12.9M Sell
1,026,793
-64,221
-6% -$1.02M ﹤0.01% 2245
2013
Q3
$18.2M Sell
1,091,014
-45,870
-4% -$769K ﹤0.01% 1934
2013
Q2
$17.3M Buy
+1,136,884
New +$17.3M ﹤0.01% 1917

Other funds holding LXRX